• Study on Octreotide for Patients with Symptomatic Polycystic Liver Disease

    Not recruiting

    4 1 1
    Investigated Drugs:
    Belgium Germany The Netherlands

  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Germany Greece Italy Romania +2

  • Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Study on Swallowing and Quality of Life in Advanced Head and Neck Cancer Patients Using Cisplatin and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Spain

  • Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Poland Spain +1

  • Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

  • Study of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain

  • Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Germany Hungary Poland

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 2 to 5 Years

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria The Netherlands

powered by